3941 |
7KFX |
HL_A |
C1A-C2 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.23 | 10.1101/2020.11.13.381533 |
3942 |
7KFY |
HL_A |
C1A-F10 Fab |
SARS-CoV-2 Spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
XRD |
2.16 | 10.1101/2020.11.13.381533 |
3943 |
7KGV |
CE_B |
7KGV Fab |
sodium-coupled neutral amino acid transporter SLC38A9 |
Danio rerio, Mus musculus |
XRD |
3.4 | 10.1016/j.str.2020.11.014 |
3944 |
7KGV |
DF_A |
7KGV Fab |
sodium-coupled neutral amino acid transporter SLC38A9 |
Danio rerio, Mus musculus |
XRD |
3.4 | 10.1016/j.str.2020.11.014 |
3945 |
7KHF |
HB_C |
MDB1 Fab |
Plasmodium RIFIN (PF3D7_1373400) V2 domain |
Homo sapiens, Plasmodium falciparum 3D7 |
EM |
3.54 | 10.1038/s41586-021-03378-6 |
3946 |
7KHF |
AL_D |
MDB1 Fab |
Plasmodium RIFIN (PF3D7_1373400) V2 domain |
Homo sapiens, Plasmodium falciparum 3D7 |
EM |
3.54 | 10.1038/s41586-021-03378-6 |
3947 |
7KI4 |
HL_B |
12B2 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus nipahense, Mus musculus |
EM |
2.9 | 10.1038/s41594-021-00584-8 |
3948 |
7KI4 |
DC_E |
12B2 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus nipahense, Mus musculus |
EM |
2.9 | 10.1038/s41594-021-00584-8 |
3949 |
7KI4 |
GF_A |
12B2 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus nipahense, Mus musculus |
EM |
2.9 | 10.1038/s41594-021-00584-8 |
3950 |
7KI6 |
HL_A |
1F5 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus hendraense, Mus musculus |
EM |
2.8 | 10.1038/s41594-021-00584-8 |
3951 |
7KI6 |
DC_B |
1F5 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus hendraense, Mus musculus |
EM |
2.8 | 10.1038/s41594-021-00584-8 |
3952 |
7KI6 |
GF_E |
1F5 Full-length |
henipaviruses (HNVs) fusion glycoprotein F0 |
Henipavirus hendraense, Mus musculus |
EM |
2.8 | 10.1038/s41594-021-00584-8 |
3953 |
7KJH |
A_C |
B9 Nanobody |
Plasmodium falciparum protein Pf12p |
Vicugna pacos, Plasmodium falciparum 3D7 |
XRD |
2 | 10.1042/BCJ20200415 |
3954 |
7KJH |
B_D |
B9 Nanobody |
Plasmodium falciparum protein Pf12p |
Vicugna pacos, Plasmodium falciparum 3D7 |
XRD |
2 | 10.1042/BCJ20200415 |
3955 |
7KJI |
A_B |
D9 Nanobody |
Plasmodium falciparum protein Pf12p |
Vicugna pacos, Plasmodium falciparum 3D7 |
XRD |
3.25 | 10.1042/BCJ20200415 |
3956 |
7KKK |
B_A |
Nb6 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.03 | 10.1126/science.abe3255 |
3957 |
7KKK |
D_C |
Nb6 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.03 | 10.1126/science.abe3255 |
3958 |
7KKK |
F_E |
Nb6 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
3.03 | 10.1126/science.abe3255 |
3959 |
7KKL |
B_A |
mNb6 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
2.85 | 10.1126/science.abe3255 |
3960 |
7KKL |
E_C |
mNb6 synthetic-Nanobody |
SARS-CoV-2 Spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, synthetic construct |
EM |
2.85 | 10.1126/science.abe3255 |